TWI329658B - Process for the manufacture of alginate-containing porous shaped articles - Google Patents
Process for the manufacture of alginate-containing porous shaped articles Download PDFInfo
- Publication number
- TWI329658B TWI329658B TW093114466A TW93114466A TWI329658B TW I329658 B TWI329658 B TW I329658B TW 093114466 A TW093114466 A TW 093114466A TW 93114466 A TW93114466 A TW 93114466A TW I329658 B TWI329658 B TW I329658B
- Authority
- TW
- Taiwan
- Prior art keywords
- alginate
- acid
- shaped article
- porous
- salt
- Prior art date
Links
- 235000010443 alginic acid Nutrition 0.000 title claims description 91
- 229920000615 alginic acid Polymers 0.000 title claims description 91
- 229940072056 alginate Drugs 0.000 title claims description 81
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 title claims description 78
- 238000000034 method Methods 0.000 title claims description 56
- 238000004519 manufacturing process Methods 0.000 title claims description 23
- 230000008569 process Effects 0.000 title description 8
- 150000003839 salts Chemical class 0.000 claims description 70
- 229910021645 metal ion Inorganic materials 0.000 claims description 41
- 239000002253 acid Substances 0.000 claims description 40
- 239000000243 solution Substances 0.000 claims description 33
- 239000002537 cosmetic Substances 0.000 claims description 32
- -1 monoterpene alginate Chemical class 0.000 claims description 29
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 230000015572 biosynthetic process Effects 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 16
- 239000002184 metal Substances 0.000 claims description 16
- 150000001450 anions Chemical class 0.000 claims description 15
- 229920002674 hyaluronan Polymers 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 229960003160 hyaluronic acid Drugs 0.000 claims description 14
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 13
- 239000008139 complexing agent Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000000783 alginic acid Substances 0.000 claims description 10
- 229960001126 alginic acid Drugs 0.000 claims description 10
- 150000004781 alginic acids Chemical class 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- 150000004804 polysaccharides Chemical class 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 7
- 239000011149 active material Substances 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000007943 implant Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 230000009969 flowable effect Effects 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000000416 hydrocolloid Substances 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229940049920 malate Drugs 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims 2
- 125000000129 anionic group Chemical group 0.000 claims 2
- RRBZUCWNYQUCTR-UHFFFAOYSA-N 2-(aminoazaniumyl)acetate Chemical compound NNCC(O)=O RRBZUCWNYQUCTR-UHFFFAOYSA-N 0.000 claims 1
- 239000010440 gypsum Substances 0.000 claims 1
- 229910052602 gypsum Inorganic materials 0.000 claims 1
- 239000000138 intercalating agent Substances 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 229930003658 monoterpene Natural products 0.000 claims 1
- 235000002577 monoterpenes Nutrition 0.000 claims 1
- 150000007519 polyprotic acids Polymers 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 36
- 239000013543 active substance Substances 0.000 description 29
- 239000000047 product Substances 0.000 description 20
- 239000001768 carboxy methyl cellulose Substances 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 8
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 8
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 8
- 235000010410 calcium alginate Nutrition 0.000 description 7
- 239000000648 calcium alginate Substances 0.000 description 7
- 229960002681 calcium alginate Drugs 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000199919 Phaeophyceae Species 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 6
- 229910021653 sulphate ion Inorganic materials 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 5
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 5
- 239000001354 calcium citrate Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 235000010413 sodium alginate Nutrition 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- 229940005550 sodium alginate Drugs 0.000 description 5
- 235000013337 tricalcium citrate Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 229910001424 calcium ion Inorganic materials 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000003111 delayed effect Effects 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 244000144927 Aloe barbadensis Species 0.000 description 3
- 235000002961 Aloe barbadensis Nutrition 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 235000011399 aloe vera Nutrition 0.000 description 3
- 239000010692 aromatic oil Substances 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000402754 Erythranthe moschata Species 0.000 description 2
- 235000014066 European mistletoe Nutrition 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 240000000950 Hippophae rhamnoides Species 0.000 description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001466453 Laminaria Species 0.000 description 2
- 241001598113 Laminaria digitata Species 0.000 description 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920002675 Polyoxyl Polymers 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 244000152640 Rhipsalis cassutha Species 0.000 description 2
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229960002009 naproxen Drugs 0.000 description 2
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 2
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- IAJILQKETJEXLJ-KKQCNMDGSA-N (2r,3r,4r,5s)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-KKQCNMDGSA-N 0.000 description 1
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 description 1
- JSRRLKCQVUJIDE-OBRACTJBSA-N (4R,4aR,7S,7aR,12bS)-9-butoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol Chemical compound C(CCC)OC=1C=CC=2C[C@@H]3[C@@H]4C=C[C@@H]([C@H]5[C@@]4(C=2C=1O5)CCN3C)O JSRRLKCQVUJIDE-OBRACTJBSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical class C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CEGRHPCDLKAHJD-UHFFFAOYSA-N 1,1,1-propanetricarboxylic acid Chemical compound CCC(C(O)=O)(C(O)=O)C(O)=O CEGRHPCDLKAHJD-UHFFFAOYSA-N 0.000 description 1
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 description 1
- 235000017334 Alcea rosea Nutrition 0.000 description 1
- 240000000530 Alcea rosea Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000017303 Althaea rosea Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 244000085625 Equisetum Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001491705 Macrocystis pyrifera Species 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- HJMPSKKJHVWPBK-UHFFFAOYSA-N N-nitrososarcosine Chemical compound O=NN(C)CC(O)=O HJMPSKKJHVWPBK-UHFFFAOYSA-N 0.000 description 1
- 101710164303 N-succinylamino acid racemase Proteins 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589755 Pseudomonas mendocina Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 235000010730 Ulex europaeus Nutrition 0.000 description 1
- 240000003864 Ulex europaeus Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- IYNWNKYVHCVUCJ-UHFFFAOYSA-N bismuth Chemical compound [Bi].[Bi] IYNWNKYVHCVUCJ-UHFFFAOYSA-N 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 229960001736 buprenorphine Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910021386 carbon form Inorganic materials 0.000 description 1
- HFNQLYDPNAZRCH-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O.OC(O)=O HFNQLYDPNAZRCH-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 229940000033 dermatological agent Drugs 0.000 description 1
- 239000003241 dermatological agent Substances 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- ADYPXRFPBQGGAH-WVVAGBSPSA-N dihydroergotoxine Chemical compound CS(O)(=O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)C1)C)C1=CC=CC=C1 ADYPXRFPBQGGAH-WVVAGBSPSA-N 0.000 description 1
- 229940120500 dihydroergotoxine Drugs 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000010647 garlic oil Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002642 intravenous therapy Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000933 neural crest Anatomy 0.000 description 1
- 101710125387 o-succinylbenzoate synthase Proteins 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229960004215 prajmaline Drugs 0.000 description 1
- UAUHEPXILIZYCU-ALHOSYKFSA-N prajmalium Chemical compound CN([C@H]12)C3=CC=CC=C3[C@]11C[C@@H]3[N@@+](CCC)([C@@H]([C@H]4CC)O)[C@H]2C[C@@H]4[C@@H]3[C@H]1O UAUHEPXILIZYCU-ALHOSYKFSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- SHALVKVVWYJLCA-UHFFFAOYSA-N propane-1,1,1,2-tetracarboxylic acid Chemical compound OC(=O)C(C)C(C(O)=O)(C(O)=O)C(O)=O SHALVKVVWYJLCA-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 235000019553 satiation Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- SONHXMAHPHADTF-UHFFFAOYSA-M sodium;2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O SONHXMAHPHADTF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229960002726 vincamine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
1329658 玖、發明說明: C ^fr ^ -=^L. ^1 本發明關於製造含褐藻酸鹽的多孔及/或似海綿狀成 形物件之方法,以及關於由此可獲得之成形物件及其等之 5 用途。 C先前技術3 發明背景 已知鹼褐藻酸鹽(諸如褐藻酸鈉)係水溶性的,但是 鹼土褐藻酸鹽(諸如褐藻酸鈣)係水不溶性的。因此,薄 ίο的水不溶層可被製造,例如,藉由以一有CaCl2之溶液來噴 霧薄褐藻酸鈉薄膜。然而,若欲求製造較厚的層係困難的, 起因於將游離鈣離子均質地併入一褐藻酸鈉溶液係因該溶 液的黏度大幅增加而顯得困難,使得未接合的褐藻酸鈣集 塊產生而取代了均勻的產品。 15 為了克服此問題,US 5,718,916建議,例如,添加 一水溶性錯合劑(諸如檸檬酸鈉)至該褐藻酸鹽組 成物的水性溶液中。若,例如,一易於溶解之鈣鹽 (諸如氣化妈)係被接續地添加,藉由該錯合劑存 在下防止了該褐藻酸鈣之立即沉澱,此係被認為防 〇止了不可'♦的褐藻酸鈣球粒形成於該產品中。然 而’ 6玄US么開案之實例係以幾毫米的規模為基礎。 該褐藻酸鹽溶液的膠化時間僅僅30至60秒。若某人 試著將此方法轉換成較大規模明顯的該所欲藉由 添加錯合劑至褐藻酸鹽溶液中之延遲作用係不足夠 5 1329658 的,以及一具有高度均質性之相對地大型產品不能 被獲得。並且’於該上述方法中’為了使該等組份 達致一足夠分散,界面活性劑之應用係絕對的。然 而,此等界面活性劑之使用可導致不对受性,如當 5 施用至皮膚時。US 5,718,916之方法無法藉由先前錯 合劑之添加達致一足夠的沉澱延缓作用之事實,亦 被該相同的發明者在GB 2357765中確認,其中該US 5,718,916之方法係因此被描述係不利的。GB 2357765揭露一用於製造供用以製造創絆膏(adhesive 10 plasters)或外科產品之水不溶性褐藻酸鹽海綿或泡沫 產品’其中水溶性褐藻酸鹽也被交聯,其藉由在一 發泡劑存在下添加多價金屬離子。目的係一錯合劑 不存在。在一較佳的變化,為了減少褐藻酸鈣之黏 度,風氧化知係存在。該實例中,例如’釣被加入, 15 隨後酸被加入。此方法也具有缺點,在酸被加入後 藉由鈣離子進行之褐藻酸鹽交聯之形成係相當快 的’所以均質的厚層不能被獲得。並且,該方法必 須有一發泡劑、界面活性劑、一硼酸鹽緩衝劑以及 上述錄化合物存在。此使得該方法難以控制,以及 20該所獲得之產品含有數個組份,其等生理影響必須 被考慮。 在DE2〇2 19 666 U中’襯墊被描述為用於皮膚科 用途,其包含一載體材料於一聚合物基底上,特別 是在一褐藻酸基底上。關於此等襯墊製造之具體的 6 1329658 實例無法從此新型專利取得。 甚者,DE 43 28 329揭露經冷凍乾燥的生物 用於皮膚之濕潤作用以及用於含天然多醣及經 的多醣之藥妝學活性物質之局部穿皮施用。此 5 案也已提及藉由添加鈣離子使褐藻酸鈣骨架形 促成生物基質穩定作用。從此公開案無法獲知 的較厚褐藻酸鹽層如何能被產生。 用於口服使用之小規模的褐藻酸鹽海綿 造,其藉由添加鈣鹽(葡萄糖酸鈣)至一褐藻 10 溶液係被描述於WO 01/17377。然而,因為其述 (鈣離子之不均質納入),此方法係不適於大型 酸鹽海綿之製造。由於其所引起之不均質性, 所建議之活性物質施用亦難以做到。 用以製造多醣泡洙體之方法,特別是一褐 15 鹽基底者,係已知於WO 94/005 12。一具體例中 專利說明書亦揭露一變化,其中一不溶的碳酸 碳酸氫鹽係藉由多價金屬陽離子被分散於經發 多醣中以及為了釋放二氧化碳及藉所形成之陽 來交聯該多醣,該發泡體接著被以一強酸處理 20 一立體穩定的泡沬體結構係被形成。根據該 案,一厚度達5 m m之泡沫體可被以此方式來穩 然而,該厚度係不足夠的,特別是將由泡沫體 的成形物件裁剪成較薄的層係所欲的。並且, 造期間產生的氣體使得難以控制孔洞尺寸且造 基質 改質 公開 成來 均質 之製 酸鈉 原因 褐藻 於此 藻酸 ,此 鹽或 泡的 離子 ,使 公開 定。 作成 在製 成該 7 1329658 泡沫體之不均質性。 製造褐藻酸鹽海綿之另一方法係已知於us 3,6 5 3,3 8 3 »於此,揭藻酸飼係先從褐藻酸及碳酸飼 製得,之後該經形成的褐藻酸鈣被沉降,且產生的 5膠被冷康乾燥。相對地大型似海綿材料可被以此方 式產生’然而’該獲得的產品相對地在水中很快速 地崩解。因此,該褐藻酸鹽海綿-特別是當裁切成薄 層時-具有不足以用於美容品或醫藥襯墊之濕強 度’特別是關於濕斷裂強度。 0 【智^明内溶_】 發明概要 因此’本發明的目的係提供相對地大型的、高度均質 的成形物件,該成形物件係以褐藻酸鹽化合物及多價金屬 15離子為基底者,其具有高程度濕強度,特別是關於濕斷 裂強度’且其可使用普遍使用之裁切裝置被裁切成 薄層’以及其具有—吸引人的表觀,亦即,特別是 一高程度白色,以及其因此可被用於美容或醫藥應 用’諸如美容皮膚襯墊或醫藥石膏等。進而,其使 20得均質的厚多孔褐藻酸鹽層之製造係可能的,該褐 薄酸鹽層輕易地經由壓製及/或衝打係適於美容品或 醫藥形式之應用且亦可被口服地投予,例如,用於植 入物之成形的物件、飽足的壓縮物(Satiati〇n comprimates)、用於活性物質之控制(特別是,延遲) 8 1329658 釋放的工具或相似者。 驚人地’本專利申請案之發明人成功地提供均質的、 相對地厚的、大型的成形物件,其係以多價金屬鹽之褐藻 s文鹽為基底’其可經由特別的方法獲得,該等方法亦是本 5發明之目的,以及該成形物件解決了上述習知技藝成形物 件的問題,以及該成形物件因此優良地適於美容品或醫藥 產品之製造。 發明之詳細說明 因此,本專利申請案提供一製造含褐藻酸鹽的多孔成 10 形物件之方法,其包含以下步驟: a)製備一水溶性褐藻酸鹽之水性溶液, bl)將一或更多的具有多牙基錯合性陰離子之多價金屬離 子鹽類添加至該水溶性褐藻酸鹽之水性溶液中以及偏移 該多價金屬離子與該多牙基錯合性陰離子的錯合物之形成 15平衡,此時該褐漢酸鹽溶液中可獲得之多價金屬離子濃度 立曰加時’且因此該褐藻酸鹽與前述多價金層離子之鹽類形 成,或者, 岣將-多價金屬離子之多牙基錯合劑添加至該水溶性褐 藻酸鹽之水性溶液中且摻合一或更多多價金屬離子的水難 20 溶性鹽類, 〇 7該(仍然)可流動的水性褐蒸酸鹽組成物倒入一模型, d)當一多孔含褐蕩酸鹽之成形物件經形成期間,將該水性 褐溱酸鹽組成物乾燥。 9 1329658 步驟a) 該使用於步驟a)中之水溶性褐藻酸鹽較佳地係鹼金屬 褐藻酸鹽,諸如:納 '钟之褐藻酸鹽…等等。 該基本的褐藻酸係一天然的酸多醣,其基本上係萃取 5自所明的褐薄(Phaecophyceae)’該多酶具有一高分子量 ’ 波動於30,000至20〇,〇〇〇道耳吞之間,其含有由D甘露糖醛 . 酸與L-葡萄糖醛酸形成之鏈。該聚合度隨著所用於萃取之 藻種類而變化’也隨著該藻被採收的季節、藻的地理來源 以及藻植物的年齡而變化。該獲取褐藻酸之主要褐藻種類 · 10 係,例如’大浮藻(Macrocy stis pyrifera)、克氏褐藻 (Laminaria cloustoni)、玄波褐藻(Laminaria hyperborean) ' 指狀褐蒸(Laminaria flexicaulis)、曲 - 莖 (Laminaria digitata) 、 大 型褐藻 (Ascophyllumnodosum)以及齒緣墨角藻(Fucus 15 s e Γ r a tu s)。然而’褐藻酸或驗褐藻酸鹽也可被以微生物 學地獲得’例如藉由綠膿假單胞菌(pseud〇m〇nas aeruginosa)或惡臭假單胞菌(pseud〇monas putida)、螢 ^ 光假單胞菌(Pseudomonas fluorescen)或門多薩假單胞 菌(Pseudomonas mendocina)等突變株之發酵作用(參 h 20 見,如 ’ EP-A-251905 以及 Rompp Chemie Lexikon ,,Naturstoffe“ Thieme Verlag,1997 以及於此載錄之 ’ 文件)。 依據本發明,褐藻酸鹽較佳係具有平均顆粒尺寸高達 約0.2 mra及在水性溶液之黏度為1 %溶液,pH 7,20。C下係 10 於其等係生理上及特別是美容品上可接受的,且相較於褐 藻酸鹽’其具有一強的交聯及/或膠化作用。此外,如:鎖、 錄、鋅、猛、鐵、铭也可被使用β 依據本發明,該多價金屬離子錯合鹽十之多牙 基錯合性陰離子較佳地係一多元羧酸之羧酸根。脂族二缓 酸至四羧酸之羧酸根,例言之,諸如:檸檬酸(2羥-HI 丙烷三羧酸)' 蘋果酸、草酸、丙烷四羧酸、蘑菇酸、 乙稀二胺四醋酸(EDTA)、1,2,3-丙烷三羧酸等等係較佳 的0 生理上耐受的’特別是皮膚耐受的’多元竣酸係特佳 的。特疋地,包括α •羥基多元羧酸之羧酸根,諸如檸檬 酸。 柃檬酸根、蘋果酸根以及EDTA陰離子係特佳的多牙基 錯合陰離子。檸檬酸根係最佳的。 依:據本發明’檸檬酸鈣(化學計量學:
Ca3Cltrate2)係較佳作為該步驟bl)所添加之具有多牙基 錯合性陰離子之多價金屬離子鹽類者。 步驟bl)中’將一具有多牙基錯合性陰離子之多價金 屬離子鹽類添加之步驟,可以固態或溶解態進行推合。 將6玄錯合鹽添加至該褐藻酸鹽溶液之步驟有利 地於5至80 C溫度範圍下進行,然而,較佳地,於室 溫下(20°C)進行。 该步驟bl)中加入的錯合物量有利地選擇係使 付该產生的溶液中錯合物鹽類的濃度量約0.1至500 1329658 較佳的酸係,例如,無機礦物酸,諸如氫氣酸、 硫酸'磷酸或脂族羧酸(如:醋酸等等)。 該被添加的酸量依隨所使用的錯合物鹽以及其 錯合物形成常數於水性溶液中。例如,其量可為約 5 該錯合物鹽濃度的0.1至20倍(mol/mol)。特定地,該 ’ 檸檬酸鈣對一酸(如,檸檬酸)之比率較佳地介於 * 0.1至20’更佳地從〇.5至10。 原則上’該pH調整到少於約6.0係足以偏移該錯 合物形成常數以供該多價金屬鹽濃度增加足夠,使 鲁 10 得超越該褐藻酸鹽產物的溶解度,意即,該不溶的 多價金屬褐藻酸鹽沉澱或該溶液膠化。 · ‘%人地,已發現此步驟中pH值調整影響所獲得 - 之多孔成形物件的斷裂強度。為了獲取一更高的斷 裂強度,少於6之pH侓係較佳的,更佳的少於5。這 15些小pH值係特佳的與一小褐藻酸濃度組合,該濃度 係經調整於步驟b)者為少於2%(wt/wt)於整體懸浮液 中。 φ 該不溶的褐藻酸鹽形成速率可被非常精確地且 谷易地控制,藉由該酸的添加量及速率,以及若有 20必要可藉由溫度控制(特別是因為該水性溶液中質 ' 子的尚擴散速率)’以及因此該褐藻酸鹽溶液或懸浮 - 液之可流動性或可傾倒性係可控制的。因此在乾燥 後可獲致高厚度係至少約i cm之均質的成形物件:、 其具有一足夠的濕強度,特別是關於濕斷裂強度, 15 1329658 使得其等可作為美容品或醫藥海綿狀濕強度材钭, 如以下所述,若有需要在後續裁切成更薄的層或藉 由壓製及/或衝打。 s _稭 步驟b2) 5 本發明方法的進一步具體例(步驟b2 )中’ 4 T ,相 較於習知技藝,進一步延遲該褐藻酸鹽溶液中不可 溶的褐藤酸鹽之形成,促使該多價金屬鹽納入該: 藻酸鹽溶液係更均質,因此,一均質品質之多孔成 开y物件產生。本發明不是(如習知技藝)藉由將一 〇可'合的夕仏金屬離子鹽類(諸如氣化鈣)添加至哕 步驟a)的褐藻酸鹽溶液俾使與褐藻酸鹽形成難溶的 鹽類’而是藉由添加此等多價金屬之難溶的鹽類, 如 CaS04。 15 20
I无,在步驟b2)將一多價金屬離子之多牙基錯 添加至該水溶性褐藻酸鹽之水性溶液中。自然地哕 基錯合劑係以-離子化合物或—共價化合物的形式; 加,例如,以一共輛酸的形式。該多牙基錯合劑可以 或溶解態被添加入該褐藻酸鹽溶液中。原則上,以上 之錯合劑可以是多價金屬離子的鹽類,該多價金屬離 形成難溶的褐藻酸鹽,也可以是不會與褐藻酸鹽形成 的化合物之單價或多價鹽類。此等金屬鹽類之混合物. 破使用°不會與褐藻酸鹽形成難溶的化合物之單價或 金屬離子鹽類(諸如:檸檬酸納,或其共耗酸,諸如; 夂)係H的’因為該多牙基陰離子對於游離多價金 ]6 5 子(係可供形成難溶性褐藻酸 顯明的。原則上,然而 &陰離子之多價金屬離子鹽類 加。 子之雑及其他變異,若需要,於摻合—多價金屬離 難溶金屬鹽(諸如,_$)之後或該期間,酸係被 :為了增加該可與㈣酸鹽形成難溶化合物之游離金 離子的濃度以及促進該褐薄酸鹽的均質交聯。較佳的酸 係,例如’無機礦物酸,諸如:氫氯酸、硫酸、罐酸或脂 族叛酸’諸如:醋酸。特定地較佳者係氫氣酸。 〜並且在步驟b2)的變異中,可預見的是訂定pH值對所獲 得的多孔成形物件之破裂強度具有影響。因此,為了獲得 -更鬲的破裂強度’一少於6的pH值係較佳的,更佳的少於 5 ’於步驟2)中也是。再者,此等小pH值特佳地係 組合一小 15 皿)形成之延遲作用,係更 於步驟bl)之騎多牙基錯合 諸如檸檬酸鈣,也可被添 該用
褐藻酸鹽濃度為經調整的在#驟b)整體懸浮液巾係小於
2%(wt/wt)。該pH值之調整,原則上,也可藉由先添加酸來 進行,諸如將HC1添加至該褐藻酸鹽溶液,或者將HC1添加 至已添加有一錯合劑(諸如,擰檬酸鈉或檸檬酸)之褐藻 酸鹽溶液’以及後續添加該難溶的金屬鹽類,如CaS 〇4。 該經添加的供用於一多價金屬離子之多牙基錯合劑量 係約0.0001至1莫耳/升,較佳的從〇 〇〇1至〇 5莫耳/升。該水 溶性褐藻酸鹽量相對於該經添加的供用於一多價金屬離子 之多牙基錯合劑莫耳量之莫耳比率較佳係0.0001比1,更佳 係 0.001 至 0.5。 17 忒被以難溶鹽類形式而在步驟b2)的第二添加步驟被 添加之多價金屬離子’其係可與褐藻酸鹽或交聯的褐藻酸 鹽形成難 >谷鹽類之金屬離子,以及在此方面我們可參照 至V驟bl)提及之鹽類。原則上該對應的陰離子可任意 地選擇’然而’在水中其等必須與該多價金屬離子或陽離 子形成難溶的鹽類。在此,鹽係較佳的,特別是硫酸妈。 CaC03,其他類似的碳酸鹽係較不佳的因為在該製備難 溶褐薄酸鹽之較佳的酸條件下可能會形成⑶2,其使得更 難控制該反應或該含褐藻酸鹽的多孔形成物件體之品質。 在v驟b2)中被添加之多價金屬離子的水難溶性鹽類 之溶解度,於2(rc水中,較佳地係小於1〇 g/升,更佳地5 g, 升更佳地0.1至3 g/升。若容解度係較高,更快的難溶性 褐藻酸鹽之形成作用可能會發生而導致一可能加工時間之 :低,且因此導致—不均質的產物。若溶解度係小於上述 範圍’該難溶性或交聯的„酸鹽之形成作用可能進行太 慢’此係非所欲的。 特別是不會形成難溶性褐藻酸鹽 氯化鈉等,該水難溶的多價金屬 ’且於是,該加工性或均質性可 藉由摻合其他鹽類, 之鹽類’諸如:硫酸鈉、 離子鹽類可被進一步減少 被增強。 /難,合的夕價金屬離子鹽類的量係視需要地選擇,使 /孤類在經產生的溶液申之濃度係約介於〇 1至5⑽ 咖〇】/升’因此’在此狀況中,係指該鹽類整體量相對於該 溶液之體積,甚至若該鹽類非完全地溶解。 1329658 該經添加的難溶性多價金屬離子鹽類量相對於該可溶 解之褐藻酸鹽量較佳地係經選擇,使得該褐藻酸鹽對該難 溶性多價金屬離子鹽類的莫耳比率係介於〇 〇〇1至i。 該經添加的難溶性多價金屬離子鹽類量相對於該經提 5供的多牙基錯合劑量較佳地係經選擇,使得該難溶性多價 金屬離子鹽類對於該多牙基錯合劑的莫耳比率係介於〇 1 至10。 依據該變異的b 1)及b 2)製程,該難溶性褐藻酸鹽之形成 作用係視所需地被控制,使得該未經錯合的雙價金屬離子 1〇濃度之增加係小的,使得該褐蒸酸鹽溶液的流動性能在室 溫下(20。〇呈現至少」分鐘,較佳地約2分鐘更佳地約3 分鐘之黏度係低於約1〇〇〇 mpas。 依據步驟bl)及b2)之褐藻酸鹽膠的形成作用或混合個 別地’較佳進行於具有定子/轉子系統之混合器,諸如:— 15 膠態碾磨機。 步驟c) 將该(仍)可流動的褐藻酸鹽組成物傾倒入—所欲用 20 來後續乾燥的模子中’可以_已知方式進行。在此,該可 流動的褐藻酸鹽組成物層之厚度能達到5GCm。較佳的妒 狀係具有-直角格式的盒形。傾倒可在本方法之任 何合適的階段進行。例如 *自步驟)之水溶性褐藻 液已經可被傾倒入該用來後續乾燥的模子中,若 痛實能在此作-充分完全之混合。較佳地:傾倒發 19 1329658 生在交聯之後或該步驟b 1)或b2)中難溶性褐藻酸的 沉澱作用已被起始之後。 步驟d) 5 步驟d)之乾燥以一已知方式進行。冷凍乾燥係
特佳地。此也能以一已知方式進行,以及,例如, DE 4328329 C2或DE 4028622 C2可被參照於本内容 中,其等能清楚地被參照於依據本發明方法步驟 d),以及其等係因此係本發明方法之一部份。 10 依據本發明方法之一較佳具體例中,至少另一 其他組份之添加係進行在步驟d)之前,特別是在步 驟c)之前,該組份係選自於一由下所構成之組群:美 容或醫藥活性的物質,其他天然或合成的水膠體成 形聚合物以及美容或醫藥的佐劑或添加劑。 15 其他天然或合成的水膠體成形聚合物包括(部
份地)水溶性、天然或合成的聚合物,其在水性系 統中形成膠狀或黏稠的溶液。其等視需要地選自其 他天然多醣、其等合成的經改質之衍生物或合成的 聚合物。其他多醣包括,如:同元聚醣或異元聚醣, 20 諸如:紅藻膠、果膠、黃蓍膠、瓜耳豆膠、角豆膠、 洋菜膠、三仙膠、天然及經改質的澱粉、類糊精、 糊精、麥芽糊精、幾丁聚醣、葡萄聚醣(諸如:β· 1,3-葡萄聚醣、β -1,4 -葡萄聚醣)、纖維素、黏多醣(如: 特別是,玻尿酸等)。合成的聚合物包括:如,纖維 20 ’、喊聚乙烤醇、聚乙烯°比D各酮、合成的纖維素衍 物諸如·甲基纖維素、羧基纖維素、羧甲基纖 維素,特別是,羧甲基纖維素鈉、纖維素酯、纖維 素転諸如.羥丙基纖維素、聚丙烯酸、聚甲基丙烯 5酸、聚(甲基丙烯酸甲酯)、聚甲基丙烯酸酯、聚乙二醇等。 · 此等聚合物之混合物也可被使用。然而,水膠體成形蛋白 - 貝諸如.膠原蛋白係不佳的,因為有些消費者增強地偏 好使用純植物來源的產品,特別是於美容品中。 依據本發明,特定地,玻尿酸及/或其鹽類及/ _ 10或其等衍生物較佳的係被添加β玻尿酸係一高度黏 稠的多醣葡萄糖胺,其具有交替的^3葡萄糖醛酸以及葡 萄糖胺部份;其分子量介於50000與數百萬之間。玻尿酸通 常係以一鈉鹽被使用於,例如,治療法,主要於眼科、外 科以及美容品。該等玻尿酸之鹽類,其中係與鹼金屬離子、 15鹼土金屬離子、鎂離子' 鋁離子、銨離子或經取代的銨離 子形成者,可被用作為載劑用以增加醫藥之吸收作用(參 見 ’ .R6mpp Chemie Lexikon ”Naturstoffe“ Thieme 鲁
Verlag,1997以及於此所載述之文件)。依據本發明, 具有分子量約1,0〇〇,〇〇〇至2,500,〇〇〇道耳吞之玻尿酸 20鈉者係特佳的。依據本發明方法’玻尿酸之添加會導致, 完全出人意料的,所獲得之含褐藻酸鹽多孔成形物件的白 - 皙度增加,特別是添加在變異bl)製程中,而在變異b2)製程 中也是。為了美觀的原因,此係非常偏好於美容品應用中。 並且,玻尿酸也被發展,特別是,於局部或區域施用之療 21 1329658 效,諸如皮膚濕潤或傷口癒合之支持。 依據本發明,該玻尿酸或其鹽類係被添加至該 含褐藻酸鹽多孔成形物件以一量約〇a至9〇重量%, 較佳地高達約70重量%,相對於該經乾燥的成形物 5 件。 10 15 20 在另一較佳的具體例中’依據本發明之含褐藻 酸鹽多孔成形物件包含羧甲基纖維素,特別是幾甲 基纖維素鈉。依據本發明,羧曱基纖維素鈉之添加 驚人地導致該含褐藻酸鹽多孔成形物件的光學密度 之改良,但不增加該成形物件的硬度或脆性。相反 地,該羧曱基纖維素鈉之添加導致所獲得之含褐藻 酸鹽多孔成形物件的撓性之改良。並且,該羧曱基 纖維素之添加,特別是羧曱基纖維素鈉之添加導致該成形物件之穩定性。在該含羧甲基纖維素之成形 物件製造期間,該羧曱基纖維素’特別是羧曱基纖 維素鈉,驚人地防止該難溶性鹽類(特別是之 >儿降。依據本發明,該錄甲其她 羧甲基纖維素,特別是羧甲基纖維素鈉,可存在於該成形物件中的量係高達 約90重量%,相對於該經乾燥的成形物件内容。此對應於被設定在該水性懸浮液中的較佳範圍係高達3 重量%,較佳地〇. 2至3重量%。
依據本發明,一較佳的占和札74· 权1土的成形物件之具體例包含 缓曱基纖維素’特別是敌曱基纖唯+細T丞纖,.隹常鈉,以及玻尿 酸及/或其等之鹽類及/或其等之衍生物。 22 1329658 特定地’經添加的活性物質包括美容或治療或 藥學活性物質’特定地適於外部施用之活性物質。 較佳地’依據本發明製造之成形物件含有至少美容 及/或藥學活性物質。據此’依據本發明之較佳的成 5形物件係美容或治療活性的物質。屬於本發明概念 下之美容用成形物件或使用美容活性物質製成之成 形物件,基本上係屬於德國食品暨日用品法規
Lebensmittel-und Bedarfsge gens tandege seizes
(LM5G)者,亦即,物質或衍生自物質之製備物係欲 10被外用在人體上用以清潔、清理目的者,或用於影 響身體外觀者,或用於傳達外表印象者,除了其等 明顯地係欲用以解除或減輕疾病、不適 '生理缺陷 或病理苦痛。此概念中,依據本發明而製造之美容 用成形物件係,例如,美容品應用諸如面膜等等, I5其此作為皮膚清洗與皮膚清潔劑、皮膚保養產品、
嘴唇保養產品、&甲保養產品、足部保養產品以及 毛髮或牙齒保養產品。 美谷有效的化合物,或任擇地,如皮膚科治 療上有效的化合物’包括:抗痘劑抗微生物劑、 20抗出汗劑' 收斂劑、去咮劑、脫毛劑、用於皮膚之 調節劑、皮膚柔順劑、增加皮膚水份劑,諸如:甘 油4、尿素、防曬劑、角質溶解劑、自由基的載收劑、 抗菌物貝、皮膚老化的徵狀之治療劑及/或皮膚分化 及/或增生及/或色素作用之調節劑、維生素(如:維 23 1329658 生素C )、具有刺激副作用之藥劑,諸如:羥酸、卜 經酸、酮酸、β,酸、維生素八類(視網醇 '視網 链視網s夂)、蔥酚(anthralines)(二氧蔥齡 (d1〇xyanthranol))、類 g 酚(anthran〇ids)、過氧化物 5 (特別是’過氧化笨曱醯)、米諾地爾( — οχ,)、 · 鐘鹽、抗代謝藥' 維生素D以及其衍生物;兒茶齡 . (catechols)、類黃酮(nav〇n〇ids)、神經醯胺 (ceramides)、脂肪物質,諸如:礦物油(如:石蠟油或凡 士林油、聚矽氧油),植物油,諸如:椰子油、甜杏仁油、 · 10杏子油、玉米油、荷荷巴油、橄欖油、酪梨油、芝麻油、 棕櫊油、尤加利油、迷迭香油、薰衣草油、松油、百里香 /由、薄荷油、菫蔻油 '甜橘花油 '黃豆油、米糠油、油菜 · 軒油、篦麻油、小麥胚芽油及由此分離出之維生素E、月見 草油、植物卵鱗脂(如’黃豆卵填脂)、分離自植物之神經 15脂質/神經醯胺、動物油或脂肪,諸如:牛脂、羊毛脂、丁 酸油、脂肪酸酯、脂醇類的酯,以及具有一對應於皮膚溫 度的熔點之蠟(動物蠟(如,蜂蠟)、棕櫚蠟及堪地里蠟、礦 ® 物蠟(如’微晶蠟))以及合成蠟(如,聚乙烯蠟或聚矽氧蠟), 以及所有適用於美容品目的之油,例如,被提及於CFTA論 20 艾” Cosmetic Ingredient Handbook, 1st edition, 1988,
The Cosmetic, Toiletry and Fragrance Association,
Inc., Washington”者,多不飽和脂肪酸、必要月旨肪酸(如: γ -次亞麻油酸)、酵素、輔酶、酵素抑制劑、保濕劑、皮 膚舒缓劑、清潔劑或產泡劑,以及非有機的或合成的磨光 24 1329658 填補劑、研磨劑。並且,植物活性物質萃取液或獲取自其 等之精華或可能提及之個別物質’皆可被添加入依據本發 明而製造之多孔性成形物體中。一般地,原則上,該植物 活性物質萃取物係經選擇自以下所構成之組群:固態植物 5萃取物、液態植物萃取物'親脂性植物萃取物、個別的植 · 物組成份’以及其等之混合物,諸如:類黃_及其等之配 . 醣基(aglycones):芸香(rutin) ' .獬皮素(quercetin)、地奥 明(diosmin)、(新)橙皮苷((neo)hesperidin) ' 橙皮素 (hesperitin)、銀杏(如:銀杏黃酮醣)、山揸(CraUegus) _ 10萃取物(如:寡聚原花青素(oligomeric procyanidines))、蕎麥(如:芸香(rutin))、槐樹(s〇ph〇ra japonica)(如:芸香(rutin))、樺木葉(如:槲皮素糖苷、 金絲桃苷 (hyperoside)以及芸香)、接骨木花 (elderflowers)(如:芸香)、萊姆(lime bl〇ssoms)(如: 15有槲皮素及金合歡醇(farnesol)之芳香油)、金絲桃油 (hypericum oil)(如:撖欖油精華)、金盞花、山金車菊 (如:有芳香油的花之脂肪性精華、有類黃酮之極性精 β 華)、蜂花(如:黃酮、芳香油);免疫刺激劑:紫錐菊(如: 醇性精華、新鮮植物汁、壓榨汁)、刺五加(Eleuther〇k〇kkus 20 senticosus),生物驗:羅夫素(rauvv〇lfia)(如:普拉馬林 (prajmaline))、桃金娘(myrtle)(如:長春蔓胺 . (vincamine)):其他植物藥劑(phytopharma cons):產薈、 西洋栗樹(如·七葉皁苦(aescin))、大蒜(如:大蒜油)、 鳳梨(鳳梨蛋白(bromelain))、人蔘(如:人蔘皂苷 25 1329658 (ginsenosides))、薊果實(如:相對於水飛薊素(silymarine) 之標準化卒取物)、金雀花根(如:魯斯可息原 (ruscogenine))、纈草(如:纈草酊(valep〇triates)、tct、 纈草萃取物(valerianae))、卡瓦卡瓦(如:卡瓦内酷 5 (kavalactones))、啤酒花(如:啤酒苦酊(h〇p biuers))、 · 西番蓮(extr. passiflorae)、龍膽(如:乙醇萃取物)、含 . 蒽醌之酊劑,如:含蘆薈素之蘆薈汁、花粉萃取物、藻類 萃取物、甘草根萃取物、棕櫚萃取物 '金英樹(如:母酊 劑)、槲寄生(mistletoe)(如:水性乙醇性精華)、植物固 籲 ίο醇(如:β-麥胚固酵(sitosterol))、毛蕊花(mulUn flowers)(如:水性乙醇性精華)、毛氈苔(Dr〇sera)(如: 甜露酒(liqueur-wine)萃取物)、海鼠李(seabuckth〇rn) - 果實(如:從此獲取之果汁或海鼠李油)、蜀葵根、櫻草根 萃取物、來自黃魁、康福利草、長春藤、木賊草、鋸葉草、 15 t大葉子(如:壓榨汁)、蓴麻' 白屈菜 '香斧、的新鮮植 物萃取物;來自諾拉那(N〇r〇laena 1〇baU)、萬壽菊、剔 歐麻(Teeoma siems)、苦瓜以及庫拉索蘆薈的植物萃取物。 · 較佳的美容活性物質係天然的以及合成的保濕 因子諸如,例如,甘油、尿素及神經酿胺、皮膚保護 2〇劑、皮膚明亮劑、維生素、抗氧化劑、所謂的抗老化劑、 - 抗紅腫劑、陽光隔絕劑等等。 · 更佳的美容活性物質係天然的脂肪與油,即, 天然脂肪酸之三酸甘.、i m 4 e h 甘'由脂’因為其等對皮膚的保濕 作用。 26 1329658 特佳的美容活性物質係尿素,其被認為具有 局部麻醉作用。 不同於上述基本上用於美容品領域之成形物 件’在用於治療上(醫藥)的成形物件中,其有一 5問題係其含有至少一藥學的或治療(特別是皮膚科 · 的)活性物質以及阿内(Arzneimittelgesetz)的認知適 . 所欲的其間用以治療、減輕或預防疾病、不適、 生理缺陷或病理困擾。此等藥劑或活性物質係所欲 用於外部施用,此狀況中需要皮膚上活性物質但也 _ 10有穿皮活性物質。其等包括’例如,用於治療皮膚 疾病之藥劑、外部施用的鎮痛劑’如’右旋普帕西芬 (Dextropr〇poxyphene)、潘他唑新(pentaz〇cine)、配西汁 (Pethidine)、丁基原啡因(BUprenorphine );抗風濕藥/消炎 藥(NSAR) ’如,美洒辛(incj〇niethacin)、雙氣芬酸 15 ( Diclofenac )、奈普生(Naproxen)、酮洛芬(Ketopr of en )、 依洛芬(ibupr0fen)、氟比洛芬(Fiurbipr〇fen)、水楊酸以 及水楊酸衍生物(諸如··乙醯水楊酸、窩羅可類( oxicam ) ) ; ^ 類固醇激素(如:貝他美刹松(betaniethasone)、)曱基培 尼松隆醇(methylprednisolone)、乙炔基雌二醇(ethynyl 20 estradiol)、曱麥角胺(medroergotamine)、二氫麥角驗 (dihydroergotoxine)、痛風治療藥(如:本補麻隆 ’ (benzbromarone)、別普林醇(Allopurinol));外用皮膚科 藥劑’包括:抗菌劑、抗黴劑 '抗病毒活性物質' 抗發炎 活性物質、止癢活性物質' 麻醉活性物質(如:苯佐卡因 27 1329658 (Benzocaine ))、腎上腺皮質素、抗痘劑、抗寄生蟲活性物 質;外用激素;靜脈治療劑;免疫抑制劑等等,所有外部 施用者。 較佳的治療劑係鎮痛劑,如免疫抑制劑、激素、 5 用於皮膚疾病(諸如:神經性皮膚炎、異位性皮膚 · 鹽等)治療之藥劑,以及抗皰疹劑。 · 並且’依據本發明製造之多孔成形物件可含有 一或多個輔助物質。輔助物質包括:填充劑、pH· 整劑(諸如:緩衝物質)、安定劑、助溶劑、藥學上 春 10及美容品上傳統的或其他染料以及色素、保存劑、 塑化劑、潤滑劑以及潤滑添加劑等等。鯊烷(Squalane) 係一特佳的輔助物質。鯊烷對皮膚具有舒緩及柔順 作用。 並且,本發明關於一具有多牙基錯合性陰離子之多 15價金屬離子鹽類用於製造含褐藻酸鹽成形物件之用途。此 意指此一鹽類係在此成形物件形成期間被添加,且非在該 成形物件的任何製造階段被部份地或完整地形成。 _ 藉由本發明手段,含有多價金屬離子褐藻酸鹽之多 孔成形物件可被製造,該物件具有至少一公分之厚 20度’較佳地至少2 cm,以及其係藉由下述而獲得: =褐藻酸鹽水性溶液與多價金屬離子之交聯(或;冗 - j )以及後續乾燥所獲得之經交聯的褐g酸之水性 …子液。於此’該成形物件的厚度意指該成形物件 兩點間取紐的距離。在此之前習知技藝無法製造 28 此厚度之大型成形物件且具有所欲的濕強度’特別 是所欲的濕破裂強度,而可被裁剪。這些多孔成形 物件較佳地係由依據本發明的製程而獲得。包括將 不可溶的褐藻酸鹽基質冷凍乾燥之製程,其導致輕 5易地分解之多孔或似海綿材料係不適用於此所欲之 · 用途β 當將該成形的物件1 g懸浮於1 〇 0 g的2 〇。C水 中’依據本發明之該多孔成形物件於該水相中具有 PH值係少於7,較佳地少於6。特別於美容皮膚上 馨 10 施用’此一酸性pH係較佳的。 依據本發明,該多孔成形物件較佳地具有一密 度為0.005至1 g/cm3,較佳地自〇 〇1至〇 5 g/cm3 (依 據 DIN 5 3 4 2 0 測定)。 依據本發明,該多孔成形物件較佳地具有一濕 15強度為至少約10 mN/mm層厚度(依據DIN 53328測 定)。 依據本發明,該多孔成形物件不含有或基本上 鲁 不含有螺旋褐藻酸鹽纖維,諸如:褐藻酸鈣纖維。 上述及之依據本發明的多孔成形物件,如上已 20 提及者’可額外地含有至少一另一搜白u π ^ ^ 砥目以下組群之 · 成分,包括:美容或醫藥活性物質 '其他天然或合 成的水勝體成形聚合物以及美容或醫藥佐 添加 劑。依據本發明,這些可被含納於該多孔成形物件 者的量係達至0.75 g/g,較佳地少於〇 5 g/g<該多孔 29 1329658 成形物件。 依據本發明,上提及之多孔成形物件係優良地 適合用於製造層狀成形物件,其係藉由已知手段來 裁切依據本發明之多孔成形物件。例言之,藉由冷 5凍乾燥該不可溶的褐藻酸鹽而獲得之似海綿材料係 無法被如上述裁切手段來製造。藉裁切依據本發明 之多孔成形物件,例如,厚度為0 5至2〇 mm之層係 被獲得。本發明亦關於由此獲得之層狀多孔成形物 件。此等層狀多孔成形物件係特別適於外部施用, 10諸如美容品或醫藥墊,諸如:用於傷口敷料之材料、 初級傷口敷料、植入材料、細胞培養基材。 並且’依據本發明之多孔成形物件係優良地適 於以勝原為基底之壓縮的、可擴展的、似海綿狀物 件之製造’例如,描述於EP 0901792申請案者。其 15等可輕易地從該大型多孔成形物件製得,其特別是 在冷凍乾燥後’藉由衝打及/或壓製來製得,而且特 别疋工業規模的’目前為止無能避免習知方法之問 題。 此類壓縮物(comprimates)係特別適於口服、σ 20腔的、鼻腔的施用,諸如,例如,可額外地含有活 性物質、用於飲食補給的物質或維生素之飽足的壓 縮物(satiation comprimates)(如:DE 19942417)。 此外’因為依據本發明的多孔性成形物件之難 溶性質’其等係適於製造經載負有活性物質之形 30 1329658 5 10 15 20 式’其中該活性物質係以 的,方式來釋放。此等形 綿’諸如:植入物、陰道 予之形式,之後,特別是 可擴張至其經壓製的體積 質釋放所含之活性物質(如 並且,本發明關於多 價金屬離子的褐藻酸鹽及 或其等衍生物。如上說明 人驚訝地’具有一增加的 於美容品,於醫藥應用也 夕孔性成形物件之組成物 該含玻尿酸之多孔性成形 方法來製造。 #且’本發明關於如 之用途或藉由本發明方法 劑之用途。較佳地,例如 性成形物件含有多價金屬 基羧酸(特別是,檸檬酸 牙基錯合劑中,在依據本 造期間。 一經控制的,特別是延遲 式包括含有活性物質之海 检劑,以及可被口服地投 壓縮物其在一潮濕狀態下 之數倍,且自其似海綿基 :WO 98/09617)。 孔性成形物件,其含有多 玻尿酸及/或其等鹽類及/ ,這些成形物件,完全令 白皙度’此係非常所欲地 是。關於該含有玻尿酸之 ’我們可參考上述說明。 物件較佳第係依據本發明 本發明之多孔性成形物件 獲得之成形物件作為美容 ’用於美容品應用該多孔 離子之褐藻酸鹽,以及羥 )可破添加於前提及之多 發明之多孔性成形物件製
容皮膚塾朝……用較佳地發 〃於潮濕形式被施用至 定曝露時間後(例如,在兮〜皮膚上且 。亥含納於其中之活 31 1329658 10 已被及收後)被取下。該褐藻酸鹽本身也 美容作用,諸如:皮膚之保水及柔順作用 並且,本發明關於如本發明之多孔性 之用途或藉由本發明方法獲得之成形物件 一醫藥產品之用途。此等醫藥產品包括, 口敷料'穿皮敷料、傷口石膏、植入物、 細胞之基質、用於控制(特別是延遲)投 質之植入物形式,也作為可被口服地投與 備物’或所謂的飽足的壓縮物其具有飽足 為該經壓縮的多孔性成形物件在胃中會擴 也可被載負有飲食補給、維生素' 礦物質 性物質。 已具有一 〇 成形物件 作為製造 例如,傷 用於培養 予活性物 之延遲製 作用,因 張。後者 或其他活
15 20 依據本發明之多孔性成形物件或 所獲得之成形物件’較佳地作為外部 由本發明方法 施用,諸如, 特別是,美容或醫藥墊。此外,如已接 巳拉及者,口服、 口腔、陰道、鼻腔施用等等係可能的。 如已述及, 依據本發明提供之由褐藻酸鹽製成 性成形物件,使得任何施用形式的 6勺土句質厚的多孔 I t規模之製造
係可行的,其藉由已知方法,諸如 壓縮及/或衝打》 裁切、壓製或 的物質(即, 特佳的成形物件,相對於該經乾,燥 無殘餘的溼度),·含有: 約6至100%褐藻酸鹽重量, 0至約90重$ %的羧曱基纖維素’特別是其鈉鹽, 32 1329658 〇至約7 0重量%的玻尿酸及/或其鹽類及/或其衍 生物, 〇至約90重量%的天然或合成的油’ 〇至約7 0重量%的棒檬酸或其鹽類, 5 之後對應於步驟c)水性懸浮液(欲被冷凍乾燥) 之較佳的範圍,係約〇 · 2至3 %褐藻酸鹽, 〇至約3重量%的羧曱基纖維素,特別是其鈉鹽, 〇至約1重量%的玻尿酸及/或其鹽類及/或其衍 生物, 10 0至約3重量%的天然或合成的油, 0至約1重量%的檸檬酸或其鹽類。 依據本發明之成形物件,較佳地具有一層形 狀’亦即,該成形物件的長度及寬度係至少10倍, 較佳地2 0倍,於該成形物件之厚度。此層也可被裁 15 切成某些形狀,如:面罩之形式。該層較佳地具有 一面積至少25 cm2 ’更佳地至少50 cm2,再佳地至少 約 100 cm2 〇 本發明亦關於含有至少一上述層之疊層物 (laminates)’其係至少一侧為該層之疊層與至少一另 20外的載層。較佳地’依據本發明之層係只有疊層在 一側’較佳地只有一載層。該載層較佳地含有一 Rayon網(膠絲)。此等疊層較佳地係被用作為傷口 敷料或石膏’以及特佳地作為美容面罩。 本發明亦關於一組合物,其含有至少一如本發 33 1329658 明之成形物件以及至少一含有一或更多活性物質及/ 或佐劑之水性溶液,於一符合的空間配置(施用包 裝、套組、部件之套件等等)。該等活性物質之溶液 可為,如:易於揮發的活性物質或佐劑之溶液,因 5 為該冷凍乾燥的製程,某些物質不應或不能被導入 該成形物件,諸如:某些精油、香精等等。並且, 該溶液亦可包含藥學或美容活性物質。 參考隨後的實例,本發明將被更詳細地描述。
I:實施方式3 10 較佳實施例之詳細說明 實例1 [製造方法1 :鈣,其係與多牙配位基錯合,此 後藉添加檸檬酸來偏移平衡] 步驟1 : 15 2500 g RO水(去鹽化的水,逆滲透) 32.5 g 褐藻酸鈉
10.0 g 擰檬酸鈣 將該褐藻酸鹽粉末加入該R 0水,以一混合器作 用直到一均質的混合物被產生。之後,將該檸檬酸 20 鈣攪入(在此階段,美容及/或醫藥活性的物質及/ 或油或其他的物質可有利地被加入該溶液,若有需 要) 步驟2 : 100 g RΟ 水 34 1329658 12.5 g 擰檬酸 該檸檬酸係在攪動下被添加至該100 ml RO水。 步驟3 : 該等步驟1及步驟2之溶液係被親密地混合約3 0 5 秒 步驟4 : 該步驟3之混合物係被導入一模子中且讓其反 應約2h。
步驟5 : 10 該膠態成形物件係經快速冷凍及經冷凍乾燥。 步驟6 : 該經冷凍乾燥的,大型多孔或似海綿成形物 件,若需要的,其係經載負有額外的物質,其可依 上述方式被製備。 15 實例2
[製造方法2 :使用一多牙基錯合劑以及之後添加水 難溶性鈣鹽] 步驟1 : 2500 g RO水(去鹽化的水,逆滲透) 20 32.5 g 褐藻酸鈉 10.0 g 檸檬酸 將該褐藻酸鹽粉末加入該RO水,以一混合器作 用直到一均質的混合物被產生。之後,將該檸檬酸 攪入(在此階段,美容及/或醫藥活性的物質及/或油 35 1329658 或其他的物質可有利地被加入該溶液,若有需要) 步驟2 : 50 g RO水 10.0 g 硫酸約 5 該硫酸鈣係在攪動下被添加至該50 ml RO水。 步驟3 : 該等步驟1及步驟2之溶液係被親密地混合約3 0 秒
步驟4 : 10 該步驟3之混合物係被導入一模子中且讓其反 應約lh。 步驟5 : 該膠態成形物件係經快速冷凍及經冷凍乾燥。 步驟6 : 15 該經冷凍乾燥的,大型多孔或似海綿成形物
件,若需要的,其係經載負有額外的物質,其可依 上述方式被製備。 【圖式簡單說明】 (無) 20 【圖式之主要元件代表符號表】 (無) 36
Claims (1)
1329658 第093114466號專利申請案申請專ΪΪΓ曰期:98^7^" -----拾_ 申請專利範圍:一孤切.2梦'》: 方法,其包含 f _製造含褐藻酸鹽之多生袅开I* 一'—一一下步驟: a)製備一水溶性褐藻酸鹽之水性溶液, 5 bl)將一或更多的具有多牙基錯合性陰離子之多價 金屬離子鹽類添加至該水溶性褐藻酸鹽之水性溶 液中,以及偏移該多價金屬離子與該多牙基錯合性 陰離子的錯合物之形成平衡,同時增加該褐藻酸鹽 溶液中可獲得之多價金屬離子濃度,且因此形成該 1〇 褐藻酸鹽與前述多價金屬離子之鹽類,或者, b2)將一多價金屬離子之多牙基錯合劑添加至該水 溶性褐藻酸鹽之水性溶液中,以及加入一或更多多 價金屬離子的水難溶性鹽類, c)將該可流動的水性褐藻酸鹽組成物倒入一模型, 15 )在多孔含褐藻酸鹽之成形物件之形成期間,將該 水性褐藻酸鹽組成物乾燥; 其中該多價金屬離子係選自—包含驗土金屬離子、鐵及 銘之群組,而該多牙基錯合性陰離子或多牙基錯合劑係 選自-含有i牙基至四牙基之陰離子性錯合性陰離子 2〇 或陰離子性錯合劑之群組。 2. 如申請專利範圍第旧之方法,其中該步驟a)之水溶性 褐藻酸鹽係一鹼金屬褐藻酸鹽。 3. 如申請專利範圍第!或2項之方法,其中該多價金屬離子 係選自於鹼土金屬離子。
37 1329658 4.如申請專利範圍第1項之方法 一妈離子。 其中該多價金屬離子係 5 10 15 5 ·如申請專利範圍第1項之士 ^ 方法,其中該多牙錯合性陰離 子或該錯合劑係分別地為—多元碳酸之幾酸根。 6. 如申請專利範圍第1項之士、| 方法,其中該多牙錯合性陰離 子或該錯合劑係分別地Α 也馬―α·羥基多元碳酸之羧酸根〇 7. 如申請專利範圍第1項之太、也4丄 4«之方法’其中該多牙錯合性陰離 子或該錯合劑係分別地进 地選自一檸檬酸根及一蘋果酸根。 8. 如申請專利範圍第丨項 ^ ^ $之方法,其中該多牙錯合性陰離 子或該錯合劑係分別地為_#樣酸根。 9·如申請專利範圍第1項之方法,其中步綱中該多價金 屬離子及該多牙錯合性降 庄陰離子之錯合物形成作用的平 衡之調節係藉由添加至少—酸而達成。 1〇.如申請專利範圍第1項之方法,其中步胸)中該經添加 的—多價金屬離子之難溶性金屬鹽呈現-溶解度係於 20°C下在水中少於1〇 g/升。 20 U·如申請專利範圍第1項之方法,其中該經添加的一多價 金屬離子之難溶性金屬鹽係硫酸鈣。 12. 如申請專利範圍第1項之方法,其中依據步驟d)之乾燥 係冷;東乾燥。 13. :申請專利範圍㈣之方法,其額外地在步驟…之 月’J ’包含添加至少另一組份,該組份係分別地選 1於以下組群:美容或醫藥的物質,其他天然或 成的水膠體成形聚合物以及美容或醫藥的佐 38 劑或添加劑。 14. 如申請專利範圍第13項之方法,其中該另一組份係至少 —天然的多酶或一經改質的多糖。 15. 如申請專利範圍第13項之方法,其中該另一組份係一玻 尿酸或其鹽類。 6·如申凊專利範圍第13項之方法,其中綾甲基纖維素或其 鹽類係被添加作為另外的組份。 17.如申請專利範圍第13項之方法,其中尿素係被添加作為 另外的組份。 1〇 18.如中請專利範圍第13項之方法’其中f、烧係被添加作為 另外的組份。 19· 一種多孔性含褐藻酸多價金屬離子鹽之成形物件,其具 有—厚度為至少一公分,且其係依據如申請專利範圍第 1項之方法來獲得。 15 20.如申請專利範圍第丨9項之多孔性成形物件,在2〇〇c下夏 g的該成形物件被懸浮於100§水中之懸浮液,達致該水 相之一pH值為少於7。 21_如申請專利範圍第19項之多孔性成形物件,其呈現一密 度依據 DIN 53420 係為 0.005 至 ig/Cm3。 20 22.如申請專利範圍第19項之多孔性成形物件其呈現 mN/mm層厚 斷裂強度依據DIN 53328係為至少1〇 度。 其包含額 於以下組 2 3 ·如申請專利範圍第丨9項之多孔性成形物件, 外至少另一組份’該組份係分別地選自 39 5 5 ’其他天然或合成的水膠 或醫藥的佐劑或添加劑。 多孔性成形物件,其包含玻尿 群:美容或醫藥的物質 體成形聚合物以及盖 久美容 24.如申請專利範圍第19項之 酸或其鹽類。 25.如申請專利範圍第 基纖維素或其鹽類 26·如申請專利範圍第 素。 19項之多孔性成形物件,其包含羧甲 〇 19項之多孔性成形物件,其包含尿 10 27.如申請專利範圍第19項 燒0 之多孔性成形物件,其包含嘗 28. :種生產層狀成形物件之方法,其藉由裁切如申請專利 範圍第1項之方法所獲得之成形物件。 29. -種生產壓製的成形物件之方法,其藉由壓製如申請專 利範圍第1項之方法所獲得之成形物件。 15 30‘如中凊專利範圍第29項之方法其係製造口服地投予之 製備物。 31 ·如申明專利範圍第29項之方法,其係製造口服地投予之 飽足的壓縮物(satiation comprimates)。 32. 如申請專利範圍第29項之方法,其係製造用於控制活性 20 物質釋放之口服地投予之製備物。 33. —種多孔性成形物件於生產一美容製備物之用途,其中 該多孔性成形物件係為如申請專利範圍第19項之多孔 性成形物件。 34· —種多孔性成形物件於生產一醫藥產品之用途,其中該 40 1329658 多孔性成形物件係為如申請專利範圍第〗 項之多孔性 成形物件。 35‘如申請專利範圍第33或34項之用途,其係用於分別地 製造一用於局部、口服、口腔、陰道或鼻腔施用之 產’或用於施用作為一植入物或傷口敷料或傷 口石膏或活性物質中之石膏之產品。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10323794A DE10323794A1 (de) | 2003-05-23 | 2003-05-23 | Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200426188A TW200426188A (en) | 2004-12-01 |
| TWI329658B true TWI329658B (en) | 2010-09-01 |
Family
ID=33441312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093114466A TWI329658B (en) | 2003-05-23 | 2004-05-21 | Process for the manufacture of alginate-containing porous shaped articles |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060280713A1 (zh) |
| EP (1) | EP1629032B1 (zh) |
| JP (1) | JP5112695B2 (zh) |
| KR (1) | KR101032125B1 (zh) |
| CN (1) | CN1795229B (zh) |
| BR (1) | BRPI0410600A (zh) |
| CA (1) | CA2520014C (zh) |
| DE (1) | DE10323794A1 (zh) |
| ES (1) | ES2727801T3 (zh) |
| RU (1) | RU2326137C2 (zh) |
| SI (1) | SI1629032T1 (zh) |
| TW (1) | TWI329658B (zh) |
| WO (1) | WO2004104076A1 (zh) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004025495A1 (de) * | 2004-05-21 | 2005-12-15 | Dr. Suwelack Skin & Health Care Ag | Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern |
| FR2925316B1 (fr) * | 2007-12-21 | 2010-02-12 | Oreal | Kit comprenant un alginate et un agent de complexation sous forme de sel insoluble dans l'eau |
| DE102008016998A1 (de) * | 2008-04-03 | 2009-10-08 | GÖPFERICH, Achim, Prof. Dr. | Langsam lösliche quervernetzte Matrices zur Verabreichung von Proteinarzneistoffen |
| US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| EP2371237B1 (de) | 2010-03-31 | 2015-08-26 | MedSkin Solutions Dr. Suwelack AG | Gesichtsmaske |
| EP2394617B1 (de) | 2010-06-10 | 2013-12-11 | MedSkin Solutions Dr. Suwelack AG | Schichtförmige perforierte Biomatrices |
| EP2545943A1 (de) | 2011-07-12 | 2013-01-16 | Dr. Suwelack Skin & Health Care AG | Perforiertes, geschichtetes Wundbehandlungsmaterial |
| GB201201751D0 (en) * | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
| EP2968108B1 (en) | 2013-03-14 | 2020-01-22 | Mary Kay, Inc. | Cosmetic compositions comprising echinacea purpurea and silybum marianum extracts |
| CN103435848B (zh) * | 2013-07-31 | 2015-06-03 | 绍兴中纺院江南分院有限公司 | 一种纤维素医用海绵的制备方法 |
| MX356307B (es) | 2013-09-17 | 2018-05-23 | Colgate Palmolive Co | Composicion para el cuidado oral. |
| CN105934238B (zh) | 2014-01-24 | 2019-11-19 | 高露洁-棕榄公司 | 具有基于藻酸盐的流变改性剂的牙膏 |
| ES2700209T3 (es) * | 2016-03-31 | 2019-02-14 | Axel Nickel | Cápsula que contiene polvo de bebida, en particular para la preparación de infusión de café |
| KR102132472B1 (ko) * | 2017-07-07 | 2020-07-09 | 재단법인 아산사회복지재단 | 열가소성 창상 드레싱 조성물 |
| RU2658046C1 (ru) * | 2017-07-11 | 2018-06-19 | Общество с ограниченной ответственностью "БЛОМ РУС" (ООО "БЛОМ РУС") | Косметическая маска для нанесения на кожу и способ ее нанесения |
| WO2019047954A1 (en) * | 2017-09-08 | 2019-03-14 | L'oreal | SKIN CARE KIT |
| CN109294001B (zh) * | 2018-08-08 | 2020-09-18 | 佛山科学技术学院 | 一种均匀内交联海藻酸钠膜及其制备方法 |
| KR102803665B1 (ko) | 2019-05-08 | 2025-05-02 | 머스큘로스켈레탈 트랜스플랜트 파운데이션 | 조직 유도된 다공질 매트릭스 및 그의 제조 및 사용 방법 |
| KR102329008B1 (ko) * | 2019-12-10 | 2021-11-18 | 중앙대학교 산학협력단 | 다공성 구조를 갖는 다당류 및 이의 제조방법 |
| DE202022106557U1 (de) | 2022-11-23 | 2022-12-02 | Elena Berkana | Netz-Gesichtsmaske |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB560317A (en) * | 1942-05-07 | 1944-03-30 | John Idris Jones | Improvements in or relating to the manufacture of low-density cellular material |
| DE1203590B (de) * | 1954-12-18 | 1965-10-21 | Budenheim Rud A Oetker Chemie | Verfahren zum Gelieren waessriger Fluessigkeiten |
| US3060032A (en) * | 1960-06-17 | 1962-10-23 | Gen Foods Corp | Freezable gels |
| SU658148A1 (ru) * | 1976-07-19 | 1979-04-25 | Всесоюзный научно-исследовательский институт медицинских полимеров | Способ получени пористого материала, обладающего ранозаживл ющим действием |
| US5211980A (en) * | 1980-10-03 | 1993-05-18 | Cox James P | Lipid pelletization methods, apparatus and products |
| JPS59502148A (ja) * | 1982-12-06 | 1984-12-27 | コツクス ジエイムズ ピ− | 脂質ペレット化方法、装置及び製品 |
| CN1007364B (zh) * | 1985-04-01 | 1990-03-28 | 基尔口/艾尔国际有限公司 | 钙的控制体系 |
| JPH01229048A (ja) * | 1988-03-09 | 1989-09-12 | Kibun Kk | ゲルの製造方法 |
| DE3827561C1 (zh) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US5502082A (en) * | 1991-12-20 | 1996-03-26 | Alliedsignal Inc. | Low density materials having good compression strength and articles formed therefrom |
| US5851461A (en) * | 1992-06-19 | 1998-12-22 | Albany International Research Co. | Method of producing polysaccharide foams |
| DE4328329C2 (de) * | 1992-08-26 | 1998-02-12 | Suwelack Nachf Dr Otto | Gefriergetrocknete Biomatrix |
| RU2035476C1 (ru) * | 1994-02-16 | 1995-05-20 | Институт пищевых веществ РАН | Способ получения пористого материала |
| GB9413932D0 (en) * | 1994-07-11 | 1994-08-31 | C V Lab Ltd | Wound dressing manufacture and use |
| GB9422343D0 (en) * | 1994-11-02 | 1994-12-21 | Merck Sharp & Dohme | Alginate ropes, method of preparation and use |
| NO953115L (no) * | 1995-06-07 | 1996-12-09 | Albany Int Research | Fremgangsmåte for fremstilling av polysakkaridskum |
| IL118376A0 (en) * | 1996-05-22 | 1996-09-12 | Univ Ben Gurion | Polysaccharide sponges for cell culture and transplantation |
| US5718916A (en) * | 1997-02-03 | 1998-02-17 | Scherr; George H. | Alginate foam products |
| JP4727028B2 (ja) * | 2000-09-08 | 2011-07-20 | 株式会社ジーシー | 歯科用アルギン酸塩印象材組成物 |
| US6696077B2 (en) * | 2001-07-26 | 2004-02-24 | George H. Scherr | Silver alginate foam compositions |
| AU2003226811A1 (en) * | 2002-04-15 | 2003-10-27 | Gunther Beisel | Agent for producing a sensation of satiety and for weight loss |
| DE20219660U1 (de) * | 2002-12-19 | 2003-02-27 | Beisel, Günther, 40789 Monheim | Schwammartiges Material |
-
2003
- 2003-05-23 DE DE10323794A patent/DE10323794A1/de not_active Withdrawn
-
2004
- 2004-05-21 BR BRPI0410600-8A patent/BRPI0410600A/pt not_active Application Discontinuation
- 2004-05-21 SI SI200432468T patent/SI1629032T1/sl unknown
- 2004-05-21 WO PCT/EP2004/050883 patent/WO2004104076A1/de not_active Ceased
- 2004-05-21 KR KR1020057022368A patent/KR101032125B1/ko not_active Expired - Lifetime
- 2004-05-21 TW TW093114466A patent/TWI329658B/zh not_active IP Right Cessation
- 2004-05-21 CA CA2520014A patent/CA2520014C/en not_active Expired - Lifetime
- 2004-05-21 CN CN2004800140675A patent/CN1795229B/zh not_active Expired - Lifetime
- 2004-05-21 US US10/557,562 patent/US20060280713A1/en not_active Abandoned
- 2004-05-21 EP EP04741624.3A patent/EP1629032B1/de not_active Expired - Lifetime
- 2004-05-21 JP JP2006530214A patent/JP5112695B2/ja not_active Expired - Lifetime
- 2004-05-21 RU RU2005140291/04A patent/RU2326137C2/ru active
- 2004-05-21 ES ES04741624T patent/ES2727801T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1629032A1 (de) | 2006-03-01 |
| JP2007505197A (ja) | 2007-03-08 |
| ES2727801T3 (es) | 2019-10-18 |
| TW200426188A (en) | 2004-12-01 |
| EP1629032B1 (de) | 2019-02-27 |
| RU2326137C2 (ru) | 2008-06-10 |
| RU2005140291A (ru) | 2007-06-27 |
| HK1090940A1 (zh) | 2007-01-05 |
| CN1795229A (zh) | 2006-06-28 |
| BRPI0410600A (pt) | 2006-06-13 |
| CA2520014A1 (en) | 2004-12-02 |
| CN1795229B (zh) | 2012-02-29 |
| KR101032125B1 (ko) | 2011-05-02 |
| US20060280713A1 (en) | 2006-12-14 |
| WO2004104076A1 (de) | 2004-12-02 |
| SI1629032T1 (sl) | 2019-09-30 |
| DE10323794A1 (de) | 2004-12-09 |
| JP5112695B2 (ja) | 2013-01-09 |
| CA2520014C (en) | 2012-12-18 |
| KR20060019554A (ko) | 2006-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI329658B (en) | Process for the manufacture of alginate-containing porous shaped articles | |
| JP4248878B2 (ja) | 二酸化炭素外用剤調製用組成物 | |
| JP4659980B2 (ja) | 二酸化炭素含有粘性組成物 | |
| CN1976983B (zh) | 含藻酸盐的多孔成型体的生产方法 | |
| WO2010143196A1 (en) | Novel synergistic transparent / translucent hydrogel composition; method of preparing it and a sheet / film made thereform | |
| CN104039305B (zh) | 含有二氧化碳的组合物的制备用试剂盒 | |
| JP4731009B2 (ja) | 外用ゲル組成物 | |
| JP2011088930A (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| US9023333B2 (en) | Method of using shaped articles to apply a scaffold-forming agent to an external skin and/or hair surface of a human or an animal | |
| JP2012149024A (ja) | 二酸化炭素外用剤調製用組成物 | |
| WO2009032325A1 (en) | Shaped items containing a human pheromone component | |
| JP2007262083A (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| JP4130181B2 (ja) | 二酸化炭素外用剤調製用組成物 | |
| HK1090940B (zh) | 用於生产含藻酸盐的多孔模塑体的方法 | |
| HK1100006B (zh) | 含藻酸盐的多孔成型体的生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Expiration of patent term of an invention patent |